Medine.co.uk

Amoxinsol 100% W/W Powder For Oral Solution

Revised: December 2012

AN: Amended Pages


SUMMARY OF PRODUCT CHARACTERISTICS


1. NAME OF THE VETERINARY MEDICINAL PRODUCT


Amoxinsol 100% w/w Powder for Oral Solution


2. QUALITATIVE AND QUANTITATIVE COMPOSITION


Amoxicillin trihydrate 100% w/w


For a full list of excipients, see section 6.1


3. PHARMACEUTICAL FORM

Powder for oral solution. A white powder.


4. CLINICAL PARTICULARS


Target species


Chickens, ducks, turkeys


4.2 Indications for use, specifying the target species


Treatment of infections in chickens, turkeys and ducks caused by bacteria susceptible to amoxicillin.

Not effective against beta-lactamase producing organisms.

Use of the product should be based on susceptibility testing and it should take into account official and local antimicrobial policies.


4.3 Contra-indications


Amoxinsol 100 should not be administered to rabbits, hamsters, gerbils and guinea pigs.


4.4 Special warnings for each target species


Do not use in animals known to be hypersensitive to the active ingredient


4.5 Special precautions for use


i. Special precautions for use in animals


None


ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals


Avoid inhalation of dust.

Wash hands after use.


Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion and skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.


Do not handle this product if you know you are sensitised or if you have been advised not to work with such preparations.


Handle this product with great care to avoid exposure, taking all recommended precautions.


If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.


Adverse reactions (frequency and seriousness)


None reported


Use during pregnancy, lactation or lay


Laboratory studies in rats have not produced any evidence of a teratogenic effect due to the administration of amoxicillin.

Interaction with other medicinal products and other forms of interaction


None reported


Amounts to be administered and administration route


The product is administered in the drinking water. Prepare the solution with fresh tap water immediately before use. Once opened, use the contents of one sachet immediately. Any unused medicated water should be discarded after 12 hours.

In order to ensure consumption of the medicated water, animals should not have access to other water supplies whilst being treated.

The following formula may be used to calculate the amount of product required per day (in grams):


Number of birds x average live weight (kg)

50 (for 20 mg/kg) or 66 (for 15 mg/kg)


To ensure a correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing. The uptake of medicated water depends on the clinical condition of the birds. In order to obtain the correct dosage the concentration of amoxicillin has to be adjusted taking into account water intake.


Chickens

The recommended dosage is 15 mg amoxicillin trihydrate per kg bodyweight.

The total period of treatment should be for 3 consecutive days or in severe cases for 5 consecutive days.


Ducks

Recommended dosage is 20 mg amoxicillin trihydrate/kg bodyweight for 3 consecutive days.


Turkeys

Recommended dosage is 15-20 mg amoxicillin trihydrate/kg bodyweight for 3 consecutive days or in severe cases for 5 consecutive days.

Overdose (symptoms, emergency procedures, antidotes), if necessary


No problems with overdosage have been reported. Treatment should be symptomatic and no specific antidote is available.


Withdrawal period(s)


Chickens (meat & offal): 1 day

Ducks (meat & offal): 9 days

Turkeys (meat & offal): 5 days

Not for use in laying birds producing eggs for human consumption


5. PHARMACOLOGICAL PROPERTIES


Summary presentation of the active ingredient: Amoxicillin is a bactericidal antibiotic belonging to the semisynthetic penicillin group. It owes its activity to the inhibition of the development of the peptidoglycan network structure in the bacterial cell wall.


Pharmacodynamic properties: Amoxicillin is a semisynthetic penicillin with a broad spectrum of activity against Gram positive and Gram negative bacteria.


Pharmacokinetic properties: Amoxicillin is well absorbed following oral administration and it is stable in the presence of gastric acids. Excretion of amoxicillin is mainly in the unchanged form via the kidneys to give high concentration in renal tissue and urine. Amoxicillin is well distributed in body fluids.


Studies in birds have indicated that amoxicillin is distributed and eliminated more rapidly than in mammals. Biotransformation appeared a more important route of elimination in birds than in mammals.


PHARMACEUTICAL PARTICULARS


List of excipients


None


Incompatibilities


None known


Shelf life


Shelf life of the veterinary medicinal product as packages for sale 18 months.

Shelf life after dilution or reconstitution according to directions 12 hours.


Special precautions for storage


Do not store above 25˚C.

Store in a dry place.

Any medicated water which is not consumed within 12 hours should be discarded.


Nature and composition of immediate packaging


75g in foil/polythene sachets, 25 sachets per box

200g in foil/polythene sachets, 10 sachets per box

Not all pack sizes may be marketed


6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


MARKETING AUTHORISATION HOLDER


Vétoquinol UK Limited

Vetoquinol House

Great Slade

Buckingham Industrial Park

Buckingham

MK18 1PA


8. MARKETING AUTHORISATION NUMBER(S)


Vm08007/4068


9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION


Date of first authorisation: UK 12 August 1996

Date of renewal of the authorisation: Indefinite with effect from 12 August 2006


10. DATE OF REVISION OF THE TEXT


Date: December 2012


Approved:

21/12/12


Page 4 of 4